2,540 Shares in CVS Health Co. (NYSE:CVS) Purchased by Oak Thistle LLC

Oak Thistle LLC acquired a new position in shares of CVS Health Co. (NYSE:CVS) in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 2,540 shares of the pharmacy operator’s stock, valued at approximately $203,000.

Other large investors have also added to or reduced their stakes in the company. Atticus Wealth Management LLC increased its stake in shares of CVS Health by 149.0% in the fourth quarter. Atticus Wealth Management LLC now owns 366 shares of the pharmacy operator’s stock worth $29,000 after purchasing an additional 219 shares in the last quarter. USA Financial Formulas increased its stake in shares of CVS Health by 573.2% in the fourth quarter. USA Financial Formulas now owns 377 shares of the pharmacy operator’s stock worth $30,000 after purchasing an additional 321 shares in the last quarter. Ables Iannone Moore & Associates Inc. purchased a new position in shares of CVS Health in the fourth quarter worth about $32,000. Creekmur Asset Management LLC purchased a new position in shares of CVS Health in the fourth quarter worth about $34,000. Finally, Steph & Co. increased its stake in shares of CVS Health by 192.0% in the first quarter. Steph & Co. now owns 438 shares of the pharmacy operator’s stock worth $35,000 after purchasing an additional 288 shares in the last quarter. Hedge funds and other institutional investors own 80.66% of the company’s stock.

Insider Activity

In related news, Director Edward J. Ludwig acquired 1,000 shares of CVS Health stock in a transaction dated Thursday, May 2nd. The shares were purchased at an average price of $53.88 per share, for a total transaction of $53,880.00. Following the completion of the transaction, the director now directly owns 21,630 shares in the company, valued at approximately $1,165,424.40. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 0.24% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages recently commented on CVS. JPMorgan Chase & Co. reduced their price objective on shares of CVS Health from $101.00 to $86.00 and set an “overweight” rating for the company in a research note on Thursday, May 30th. TD Cowen cut shares of CVS Health from a “buy” rating to a “hold” rating and cut their price objective for the company from $99.00 to $59.00 in a research note on Tuesday, May 7th. Piper Sandler upped their price objective on shares of CVS Health from $93.00 to $94.00 and gave the company an “overweight” rating in a research note on Friday, March 15th. The Goldman Sachs Group cut their price objective on shares of CVS Health from $85.00 to $74.00 and set a “buy” rating for the company in a research note on Thursday, May 2nd. Finally, Mizuho dropped their price target on shares of CVS Health from $86.00 to $72.00 and set a “buy” rating for the company in a research report on Thursday, May 2nd. Eleven research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to MarketBeat, CVS Health currently has a consensus rating of “Moderate Buy” and an average target price of $75.05.

CVS Health Stock Performance

CVS opened at $58.14 on Tuesday. The company has a current ratio of 0.81, a quick ratio of 0.61 and a debt-to-equity ratio of 0.78. CVS Health Co. has a 12-month low of $52.77 and a 12-month high of $83.25. The company has a market cap of $72.99 billion, a price-to-earnings ratio of 10.22, a PEG ratio of 0.56 and a beta of 0.52. The company’s 50 day moving average is $59.56 and its 200 day moving average is $70.13.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Wednesday, May 1st. The pharmacy operator reported $1.31 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.69 by ($0.38). The company had revenue of $88.44 billion for the quarter, compared to the consensus estimate of $89.33 billion. CVS Health had a net margin of 2.03% and a return on equity of 13.53%. The company’s quarterly revenue was up 3.7% on a year-over-year basis. During the same quarter in the previous year, the business earned $2.20 EPS. On average, equities research analysts predict that CVS Health Co. will post 7.02 EPS for the current year.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.